CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biosynex SA Company Snapshot
Biosynex SA operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other pharmaceutical manufacturers in Europe: Biohit Oyj of Finland (2016 sales of 8.20 million Euro [US$9.20 million] ), RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS of Turkey (31.81 million Turkish Liras [US$8.94 million] ), and Immunodiagnostic System HDQ which is based in the United Kingdom (£38.31 million [US$49.68 million] of which 100% was Medical Diagnostic).

Sales Analysis. During the year ended December of 2016, sales at Biosynex SA were 27.00 million Euro (US$30.30 million). This is an increase of 34.1% versus 2015, when the company's sales were 20.13 million Euro. This was the fifth consecutive year of sales increases at Biosynex SA (and since 2011, sales have increased a total of 2,470%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biosynex SA
  Stock Performance Chart for Biosynex SA
 
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 4.16
(Figures in Euro)
1 Week 1.5%   13 Weeks -1.7%  
4 Weeks 23.4%   52 Weeks 42.2%  
 
Biosynex SA Key Data:
  Ticker: ALBIO Country: France
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 27,000,000
(Year Ending Jan 2017).
Employees: 49
  Currency: Euro Market Cap: 26,442,854
  Fiscal Yr Ends: December Shares Outstanding: 6,356,455
  Share Type: Actions Ordinaires Closely Held Shares: 481,751
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.